Hetero inks voluntary licensing pact with Gilead for HIV drug lenacapavir
|
Lenacapavir works with other anti-retroviral drugs to
treat multi-drug-resistant HIV-1 infections. |
Why scientists want people living with HIV to start using climate-friendly ARVS
... antiretroviral (ARV) largely used in Kenya that they say is not climate-friendly due to high greenhouse gas (GHG) emissions. Speaking to Healthy ... View article...